- Home
- BTBD vs BRTX Comparison
BTBD vs BRTX Comparison
Compare BTBD & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BTBD | BRTX |
|---|---|---|
| Founded | 1987 | 1997 |
| Country | United States | United States |
| Employees | 188 | N/A |
| Industry | Restaurants | Managed Health Care |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2M | 6.3M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | BTBD | BRTX |
|---|---|---|
| Price | $1.12 | $0.29 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 19.8K | ★ 290.8K |
| Earning Date | 05-15-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $81,000.00 |
| Revenue This Year | N/A | $298.39 |
| Revenue Next Year | N/A | $64.62 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.03 | $0.16 |
| 52 Week High | $5.59 | $1.89 |
Technical Indicators
Market Signals| Indicator | BTBD | BRTX |
|---|---|---|
| Relative Strength Index (RSI) | 48.76 | 38.26 |
| Support Level | $1.03 | $0.21 |
| Resistance Level | $1.17 | $0.32 |
| Average True Range (ATR) | 0.05 | 0.03 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 44.44 | 3.01 |
Price Performance
Historical ComparisonAbout BTBD BT Brands Inc.
BT Brands Inc operates and owns a fast-food restaurant called Burger Time. Its offerings include a variety of burgers and other affordable items, including sides and soft drinks. The company owns and operates Keegan's Seafood Grille (Keegan's), a dine-in restaurant located in Florida; Pie In The Sky Coffee and Bakery (PIE), located in Massachusetts; and Schnitzel Haus, a German-themed restaurant located in Florida. The company's revenues are derived from the sale of food and beverages at its restaurants.
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.